Mark Cuban: Cost Plus Drugs scaled from 100 to 4,000 generics at a flat 15% markup
a16z · x · 2026-10-28
In an a16z podcast with Julie Yoo and Erik Torenberg, Mark Cuban walks through Cost Plus Drugs' playbook:
- Scaled from 111 generics to 4,000 drugs at a flat 15% markup, forcing incumbents to change prices in ways decades of policy never did
- Argues trust is the core product, and transparency is the lever to pressure healthcare costs
- Covers a football field-sized drug plant shrunk into tractor-trailer-sized pods, and plans to make generics in Dallas cheaper than buying from India
- Discusses DNA-tailored drugs costing close to nothing, and why every company must get great at AI or die
He also cautions that AI alone won't fix opaque pricing and broken incentives in healthcare.
Related event: Mark Cuban on Cost Plus Drugs Growth and AI-Driven Healthcare Costs(2 posts)→
More from Companies & People
- Nathan Benaich: Bending Spoons and data companies are the grim reapers of SaaS — nathanbenaich · 2026-10-29
- Liquid AI's Leonie Monigatti to demo 100% local decision models at AI Engineer Shanghai — helloiamleonie · 2026-10-29
- GitHub Universe 2026 Opens: Keynote News Live-Tracked — kimmonismus · 2026-10-28
- Could iMessage Agents Be Apple's Next App Store-Scale Business? — signulll · 2026-10-28
- TechCrunch: AI execs flaunting family AI use shows how out of touch they are — TechCrunch AI · 2026-10-28
- QNX expands from millions of vehicles to robotics and physical AI — pdamodaran · 2026-10-28